MANULIFE US REIT (SGX:BTOU)
Manulife US REIT - On The Lookout To Capture Growth
- Manulife US REIT’s portfolio saw slight positive rental reversion in 1Q21. A sizeable 270,000sf of leases were executed, mainly done with renewals, although the company’s portfolio occupancy dipped slightly.
- Manulife US REIT continues to highlight its plans to capture demand from high-growth trade sectors such as tech and healthcare tenants.
- Maintain BUY with a target price of US$0.87.
Manulife US REIT (MUST) provided operating and financial metrics for 1Q21.
Slight positive in rental reversion.
- Manulife US REIT (SGX:BTOU) saw a positive rental reversion of 2.1% in 1Q21 (2020: 4.7% excluding mark-to-market lease), mainly from finance and insurance, administrative, advertising and legal sectors. Leasing in 1Q21 was mainly done for renewals (about 94%), with minimal new leases. According the management, prospective tenants were active but cautious. The 270,000sf of leases executed was about 5.8% of its portfolio’s NLA. This has reduced lease expiries in 2021 to 4.3% of NLA (from 5.7%), and 2022 to 13.0% of NLA (from 18.1%).
Lower portfolio occupancy.
- Portfolio occupancy fell to 92% (2020: 93.4%) though this was still above US Class-A average occupancy of 82%. Manulife US REIT noted that existing vacancies remains a challenge, with larger spaces taking a longer time to fill.
Cost savings from lower weighted average interest rate.
- Manulife US REIT recently obtained a US$250m sustainability-linked loan which incorporates interest-rate reductions linked to predetermined sustainability performance targets. Weighted average interest rate was lowered to 3.0% in Apr 21 (vs 3.18% in 2020) while weighted average debt to maturity increased to 3.4 years (vs 2.3 years in 2020).
Steady WALE and gearing.
- Gearing levels were unchanged at 41.3% in 1Q21. The portfolio’s long WALE is also intact, with 49% of leases by NLA expiring in 2026 and beyond. The top 10 tenants accounted for 36% of the gross rental income in 1Q21 with rental collection in 1Q21 robust at 98%.
STOCK IMPACT
Transformational growth.
- Manulife US REIT continues to highlight its plans to capture demand from high-growth trade sector such as tech and healthcare tenants. Current tenant exposure in such sectors accounts for 10% of Manulife US REIT’s portfolio, and the company intends to grow this segment of tenants to account for approximately 20% of tenant base. This could also take the form of JVs or M&As, through the acquisition of yield-accretive properties or portfolio.
- Manulife US REIT prefers key locations with strong fundamentals such as cities with robust population growth and increasing rental rates. An example is the Sun Belt region which has seen a 1.6% growth in population size p.a., and has a lower cost of living compared to gateway cities.
Physical occupancy has room for improvement.
- Current physical occupancy in Manulife US REIT’s portfolio remains low, at only 5-25% as of end-Apr 21, affecting carpark income. Vaccination rollout has been swift in the US. According to the Centers for Disease Control & Prevention, the current proportion of population who have received at least one dose of vaccine in various key regions is as follows: California (52%), New Jersey (55%), and Georgia (37%).
Manulife US REIT’s Class-A assets still stand in good stead
- Manulife US REIT’s Class-A assets still stand in good stead compared with the market’s occupancy rates. According to JLL, net effective rents for 1Q21 in CBD Class-A space have dipped 13% below pre-pandemic levels, though the decline appears to have slowed down.
EARNINGS REVISION/RISK
- None.
VALUATION/RECOMMENDATION
- Maintain BUY with a target price of US$0.87, based on DDM (required rate of return: 8.0% terminal growth: 1.0%).
- Key risks: Slowdown in the US economy, affecting demand for office space.
- See
SHARE PRICE CATALYST
- Better-than-expected rental reversion.
- Return to office in the US.
Lucas Teng
UOB Kay Hian Research
|
Jonathan KOH CFA
UOB Kay Hian
|
https://research.uobkayhian.com/
2021-05-17
SGX Stock
Analyst Report
0.870
SAME
0.870